Jesus C Fabregas, MD, MPH, FACP

Jesus C. Fabregas, MD, MPH, FACP is an Assistant Professor of Medicine in the Division of Hematology & Oncology at the University of Florida College of Medicine.

Dr. Fabregas received his medical degree from Universidad Del Norte in Colombia. Following medical school, he completed his internship and residency in Internal Medicine at the University of Miami, Miller School of Medicine in Miami, Florida, where he earned the American College of Physicians Outstanding Resident Award. He then finished a post-doctorate fellowship in hematology and oncology at Sylvester Cancer Center – University of Miami.

Dr. Fabregas most recently completed his Master of Public Health degree in Epidemiology from Harvard University – Harvard TH Chan School of Public Health. As part of his public health efforts, his research evaluated inequities and the impact of social determinants of health in cancer care in the US.

At UF Health, Dr. Fabregas will take care of patients with gastrointestinal malignancies, with a special interest in colon and rectal cancer, using a multi-disciplinary approach. He aims to improve patient’s quality of life and to provide personalized care by accessing the latest targeted and immunotherapy treatments through clinical trials.

His recent research endeavors included a meta-analysis studying the feasibility of minimizing toxicities in patients with early rectal cancer, and refining prognosis and treatment selection for patients with early colon cancer applying a machine-learning model. He has presented the results of his research in several oncology society meetings including American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and European Society of Medical Oncology – GI (ESMO-GI).

He is board certified in Medical Oncology, Hematology and Internal Medicine with the American Board of Internal Medicine. He is a member of the American Society of Clinical Oncology and a Fellow of the American College of Physicians.

In addition to his passion about oncology, Dr. Fabregas enjoys spending time with his family, hiking, traveling and exploring the outdoors.

• Hematology

  American Board of Internal Medicine
• Internal Medicine

  American Board of Internal Medicine
• Medical Oncology

  American Board of Internal Medicine

0000-0003-1120-1783

• Association between Socioeconomic Determinants of Health
• Clinical trials in gastrointestinal malignancies – colorectal, pancreas, esophagogastric, hepatobiliary, neuroendocrine tumors.
• Disparities in cancer outcomes
• Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision
• Epidemiology and public health
• Immunotherapy
• Impact of Medicaid Expansion Status and Race on a Late Diagnosis of Melanoma
• Minimizing toxicities in patients with early rectal cancer
• Personalized medicine, next generation sequencing
• Quality of life
• Refining prognosis and treatment selection for patients with early colon cancer